Toro, Diana Mota; Silva Neto, Pedro Vieira da 
; Carvalho, Jonatan Constança Silva de ; Fuzo, Carlos Alessandro ; Pérez, Malena Martínez; Pimentel, Vinícius Eduardo ; Fraga-Silva, Thais Fernanda de Campos ; Oliveira, Camilla N. S; Caruso, Glaucia Rigotto ; Vilela, Adriana Ferreira Lopes ; Azevedo, Pedro Nobre ; Felippe, Thiago Vinicius Defelippo ; Argolo, Jamille Guedes Malta; Degiovani, Augusto Marcussi; Ostini, Fátima M; Feitosa, Marley Ribeiro ; Parra, Rogério Serafim ; Vilar, Fernando C; Gaspar, Gilberto Gambero ; Rocha, José Joaquim Ribeiro da ; Féres, Omar ; Costa, Gabriel Peinado ; Maruyama, Sandra R. C; Russo, Elisa Maria de Sousa ; Fernandes, Ana Paula Morais ; Santos, Isabel Kinney Ferreira de Miranda ; Malheiro, Adriana; Sadikot, Ruxana T; Bonato, Vânia Luiza Deperon ; Cardoso, Cristina Ribeiro de Barros ; Dias-Baruffi, Marcelo ; Trapé, Átila Alexandre ; Faccioli, Lucia Helena ; Sorgi, Carlos Arterio
Fonte: Cells. Nome do evento: ImmunoCovid Consortium Group. Unidades: FMRP, FCFRP, EERP, EEFERP, FFCLRP, Interunidades em Enfermagem
Assuntos: BIOMARCADORES, COVID-19, PROGNÓSTICO, INFLAMAÇÃO
ABNT
TORO, Diana Mota et al. Plasma sphingomyelin disturbances: unveiling its dual role as a crucial immunopathological factor and a severity prognostic biomarker in COVID-19. Cells, v. 12, n. 15, 2023Tradução . . Disponível em: https://doi.org/10.3390/cells12151938. Acesso em: 08 nov. 2025.APA
Toro, D. M., Silva Neto, P. V. da, Carvalho, J. C. S. de, Fuzo, C. A., Pérez, M. M., Pimentel, V. E., et al. (2023). Plasma sphingomyelin disturbances: unveiling its dual role as a crucial immunopathological factor and a severity prognostic biomarker in COVID-19. Cells, 12( 15). doi:10.3390/cells12151938NLM
Toro DM, Silva Neto PV da, Carvalho JCS de, Fuzo CA, Pérez MM, Pimentel VE, Fraga-Silva TF de C, Oliveira CNS, Caruso GR, Vilela AFL, Azevedo PN, Felippe TVD, Argolo JGM, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Costa GP, Maruyama SRC, Russo EM de S, Fernandes APM, Santos IKF de M, Malheiro A, Sadikot RT, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Trapé ÁA, Faccioli LH, Sorgi CA. Plasma sphingomyelin disturbances: unveiling its dual role as a crucial immunopathological factor and a severity prognostic biomarker in COVID-19 [Internet]. Cells. 2023 ; 12( 15):[citado 2025 nov. 08 ] Available from: https://doi.org/10.3390/cells12151938Vancouver
Toro DM, Silva Neto PV da, Carvalho JCS de, Fuzo CA, Pérez MM, Pimentel VE, Fraga-Silva TF de C, Oliveira CNS, Caruso GR, Vilela AFL, Azevedo PN, Felippe TVD, Argolo JGM, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Costa GP, Maruyama SRC, Russo EM de S, Fernandes APM, Santos IKF de M, Malheiro A, Sadikot RT, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Trapé ÁA, Faccioli LH, Sorgi CA. Plasma sphingomyelin disturbances: unveiling its dual role as a crucial immunopathological factor and a severity prognostic biomarker in COVID-19 [Internet]. Cells. 2023 ; 12( 15):[citado 2025 nov. 08 ] Available from: https://doi.org/10.3390/cells12151938
